Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) |
| BNF code | 0801050Q0BCAAAE |
| Virtual Medicinal Product | Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials |
| Name | Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials |
| Abbreviated name | Onivyde pegylated liposomal 43mg/10ml concentrate for inf |
| Date of name applicability | 1 May 2021 |
| Previous name | Onivyde pegylated liposomal 43mg/10ml concentrate for solution for infusion vials |
| Supplier | Servier Laboratories Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.